Last reviewed · How we verify

chirocaine (Levobupivacaine)

Centre Hospitalier Universitaire de Saint Etienne · Phase 3 active Small molecule

chirocaine (Levobupivacaine) is a Local anesthetic Small molecule drug developed by Centre Hospitalier Universitaire de Saint Etienne. It is currently in Phase 3 development for Regional anesthesia for surgical procedures, Pain management for chronic pain conditions.

Chirocaine (Levobupivacaine) is a local anesthetic that blocks nerve impulses by inhibiting sodium channels.

Chirocaine (Levobupivacaine) is a local anesthetic that blocks nerve impulses by inhibiting sodium channels. Used for Regional anesthesia for surgical procedures, Pain management for chronic pain conditions.

At a glance

Generic namechirocaine (Levobupivacaine)
SponsorCentre Hospitalier Universitaire de Saint Etienne
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 3

Mechanism of action

This action prevents the transmission of pain signals to the brain, resulting in a temporary loss of sensation in the affected area. Levobupivacaine has a slower onset and longer duration of action compared to other local anesthetics, making it suitable for procedures requiring prolonged anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about chirocaine (Levobupivacaine)

What is chirocaine (Levobupivacaine)?

chirocaine (Levobupivacaine) is a Local anesthetic drug developed by Centre Hospitalier Universitaire de Saint Etienne, indicated for Regional anesthesia for surgical procedures, Pain management for chronic pain conditions.

How does chirocaine (Levobupivacaine) work?

Chirocaine (Levobupivacaine) is a local anesthetic that blocks nerve impulses by inhibiting sodium channels.

What is chirocaine (Levobupivacaine) used for?

chirocaine (Levobupivacaine) is indicated for Regional anesthesia for surgical procedures, Pain management for chronic pain conditions.

Who makes chirocaine (Levobupivacaine)?

chirocaine (Levobupivacaine) is developed by Centre Hospitalier Universitaire de Saint Etienne (see full Centre Hospitalier Universitaire de Saint Etienne pipeline at /company/centre-hospitalier-universitaire-de-saint-etienne).

What drug class is chirocaine (Levobupivacaine) in?

chirocaine (Levobupivacaine) belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is chirocaine (Levobupivacaine) in?

chirocaine (Levobupivacaine) is in Phase 3.

What are the side effects of chirocaine (Levobupivacaine)?

Common side effects of chirocaine (Levobupivacaine) include Numbness or tingling, Headache, Dizziness, Nausea, Vomiting, Hypotension.

What does chirocaine (Levobupivacaine) target?

chirocaine (Levobupivacaine) targets Voltage-gated sodium channels and is a Local anesthetic.

Related